Advertisement
Screener

PRECIGEN, INC. (PGEN) Increase (Decrease) in Accounts Receivable

2.8 / 5 stars · 68/120 Roast Me

PRECIGEN, INC. Increase (Decrease) in Accounts Receivable

PRECIGEN, INC. (PGEN) reported Increase (Decrease) in Accounts Receivable of $67.95 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-04

  • PRECIGEN, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $45.46M.
  • PRECIGEN, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $22.49M.
  • PRECIGEN, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $3.34M, a 646.31% increase year-over-year.
  • PRECIGEN, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $253.00K.
  • PRECIGEN, INC. increase (decrease) in accounts receivable for fiscal 2025 was $2.99M, a 12358.33% increase from fiscal 2024.
  • PRECIGEN, INC. increase (decrease) in accounts receivable for fiscal 2024 was $24.00K.
  • PRECIGEN, INC. increase (decrease) in accounts receivable for fiscal 2023 was -$76.00K, a 103.49% decline from fiscal 2022.
  • PRECIGEN, INC. increase (decrease) in accounts receivable for fiscal 2022 was $2.17M, a 65.09% decline from fiscal 2021.
Period endIncrease (Decrease) in Accounts Receivable 3 monthIncrease (Decrease) in Accounts Receivable 3 month as first filedIncrease (Decrease) in Accounts Receivable 6 monthIncrease (Decrease) in Accounts Receivable 6 month as first filedIncrease (Decrease) in Accounts Receivable 9 monthIncrease (Decrease) in Accounts Receivable 12 monthIncrease (Decrease) in Accounts Receivable 12 month as first filed
2026-06-30$45.46M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
$67.95M
10-Q · filed 2026-08-04
$71.29M
derived: sum of 3 quarters · filed 2026-08-04
$71.54M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31$22.49M
10-Q · filed 2026-05-13
$25.82M
derived: sum of 2 quarters · filed 2026-05-13
$26.08M
derived: sum of 3 quarters · filed 2026-05-13
$25.65M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31$3.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
$3.59M
derived: sum of 2 quarters · filed 2026-03-25
$3.17M
derived: sum of 3 quarters · filed 2026-08-04
$2.99M
10-K · filed 2026-03-25
2025-09-30$253.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$171.00K
derived: sum of 2 quarters · filed 2026-08-04
-$346.00K
10-Q · filed 2025-11-13
$101.00K
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30-$424.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
-$599.00K
10-Q · filed 2026-08-04
-$152.00K
derived: sum of 3 quarters · filed 2026-08-04
-$184.00K
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31-$175.00K
10-Q · filed 2026-05-13
$272.00K
derived: sum of 2 quarters · filed 2026-05-13
$240.00K
derived: sum of 3 quarters · filed 2026-05-13
-$121.00K
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$447.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
$415.00K
derived: sum of 2 quarters · filed 2026-03-25
$54.00K
derived: sum of 3 quarters · filed 2026-03-25
$24.00K
10-K · filed 2026-03-25
2024-09-30-$32.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$393.00K
derived: sum of 2 quarters · filed 2025-11-13
-$423.00K
10-Q · filed 2025-11-13
-$509.00K
derived: sum of 4 quarters · filed 2026-03-25
2024-06-30-$361.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
-$391.00K
10-Q · filed 2025-08-12
-$477.00K
derived: sum of 3 quarters · filed 2026-03-25
-$843.00K
derived: sum of 4 quarters · filed 2026-03-25
2024-03-31-$30.00K
10-Q · filed 2025-05-14
-$116.00K
derived: sum of 2 quarters · filed 2026-03-25
-$482.00K
derived: sum of 3 quarters · filed 2026-03-25
-$899.00K
derived: sum of 4 quarters · filed 2026-03-25
2023-12-31-$86.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
-$452.00K
derived: sum of 2 quarters · filed 2026-03-25
-$869.00K
derived: sum of 3 quarters · filed 2026-03-25
-$76.00K
10-K · filed 2026-03-25
2023-09-30-$366.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
-$783.00K
derived: sum of 2 quarters · filed 2024-11-14
$10.00K
10-Q · filed 2024-11-14
-$261.00K
derived: sum of 4 quarters · filed 2025-03-19
2023-06-30-$417.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14
$376.00K
10-Q · filed 2024-08-14
$105.00K
derived: sum of 3 quarters · filed 2025-03-19
-$4.46M
derived: sum of 4 quarters · filed 2025-03-19
2023-03-31$793.00K
10-Q · filed 2024-05-14
$522.00K
derived: sum of 2 quarters · filed 2025-03-19
-$4.05M
derived: sum of 3 quarters · filed 2025-03-19
-$670.00K
derived: sum of 4 quarters · filed 2025-03-19
2022-12-31-$271.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19
-$4.84M
derived: sum of 2 quarters · filed 2025-03-19
-$1.46M
derived: sum of 3 quarters · filed 2025-03-19
$2.17M
10-K · filed 2025-03-19
$2.23M
10-K · filed 2023-03-06
2022-09-30-$4.57M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
-$1.19M
derived: sum of 2 quarters · filed 2023-11-09
$2.45M
10-Q · filed 2023-11-09
$3.39M
derived: sum of 4 quarters · filed 2024-03-19
2022-06-30$3.38M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$7.02M
10-Q · filed 2023-08-09
$7.07M
10-Q · filed 2022-08-08
$7.96M
derived: sum of 3 quarters · filed 2024-03-19
$2.67M
derived: sum of 4 quarters · filed 2024-03-19
2022-03-31$3.64M
10-Q · filed 2023-05-10
$3.70M
10-Q · filed 2022-05-09
$4.58M
derived: sum of 2 quarters · filed 2024-03-19
-$713.00K
derived: sum of 3 quarters · filed 2024-03-19
$4.92M
derived: sum of 4 quarters · filed 2024-03-19
2021-12-31$945.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19
-$4.35M
derived: sum of 2 quarters · filed 2024-03-19
$1.28M
derived: sum of 3 quarters · filed 2024-03-19
$6.23M
10-K · filed 2024-03-19
$6.18M
10-K · filed 2022-03-01
2021-09-30-$5.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$336.00K
derived: sum of 2 quarters · filed 2022-11-09
$5.29M
10-Q · filed 2022-11-09
$4.02M
derived: sum of 4 quarters · filed 2023-03-06
2021-06-30$5.63M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
$10.58M
10-Q · filed 2022-08-08
$9.32M
derived: sum of 3 quarters · filed 2023-03-06
$4.69M
derived: sum of 4 quarters · filed 2023-03-06
2021-03-31$4.95M
10-Q · filed 2022-05-09
$3.69M
derived: sum of 2 quarters · filed 2023-03-06
-$944.00K
derived: sum of 3 quarters · filed 2023-03-06
$3.17M
derived: sum of 4 quarters · filed 2023-03-06
2020-12-31-$1.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06
-$5.89M
derived: sum of 2 quarters · filed 2023-03-06
-$1.78M
derived: sum of 3 quarters · filed 2023-03-06
-$2.21M
10-K · filed 2023-03-06
2020-09-30-$4.63M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08
-$514.00K
derived: sum of 2 quarters · filed 2021-11-08
-$952.00K
10-Q · filed 2021-11-08
-$449.00K
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$4.12M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
$3.68M
10-Q · filed 2021-08-09
$4.18M
derived: sum of 3 quarters · filed 2022-03-01
$198.00K
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31-$438.00K
10-Q · filed 2021-05-10
$65.00K
derived: sum of 2 quarters · filed 2022-03-01
-$3.92M
derived: sum of 3 quarters · filed 2022-03-01
$1.13M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$503.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
-$3.48M
derived: sum of 2 quarters · filed 2022-03-01
$1.57M
derived: sum of 3 quarters · filed 2022-03-01
$262.00K
10-K · filed 2022-03-01
2019-09-30-$3.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$1.06M
derived: sum of 2 quarters · filed 2020-11-09
-$241.00K
10-Q · filed 2020-11-09
$2.86M
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30$5.05M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
$3.74M
10-Q · filed 2020-08-10
$6.84M
derived: sum of 3 quarters · filed 2021-03-01
$2.80M
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31-$1.31M
10-Q · filed 2020-05-11
$1.79M
derived: sum of 2 quarters · filed 2021-03-01
-$2.25M
derived: sum of 3 quarters · filed 2021-03-01
$3.25M
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31$3.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
-$941.00K
derived: sum of 2 quarters · filed 2021-03-01
$4.55M
derived: sum of 3 quarters · filed 2021-03-01
$2.70M
10-K · filed 2021-03-01
2018-09-30-$4.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$1.46M
derived: sum of 2 quarters · filed 2019-11-12
-$399.00K
10-Q · filed 2019-11-12
$1.35M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30$5.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$3.64M
10-Q · filed 2019-08-09
$5.39M
derived: sum of 3 quarters · filed 2020-03-02
$1.20M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31-$1.86M
10-Q · filed 2019-05-09
-$105.00K
derived: sum of 2 quarters · filed 2020-03-02
-$4.30M
derived: sum of 3 quarters · filed 2020-03-02
-$665.00K
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31$1.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
-$2.44M
derived: sum of 2 quarters · filed 2020-03-02
$1.19M
derived: sum of 3 quarters · filed 2020-03-02
-$740.00K
10-K · filed 2020-03-02
2017-09-30-$4.19M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
-$560.00K
derived: sum of 2 quarters · filed 2018-11-08
-$2.49M
10-Q · filed 2018-11-08
-$2.96M
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30$3.63M
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-13
$1.70M
10-Q · filed 2018-08-13
$1.23M
derived: sum of 3 quarters · filed 2019-03-01
-$3.35M
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31-$1.93M
10-Q/A · filed 2018-08-13
-$2.40M
derived: sum of 2 quarters · filed 2019-03-01
-$6.98M
derived: sum of 3 quarters · filed 2019-03-01
-$1.50M
derived: sum of 4 quarters · filed 2019-03-01
2016-12-31-$470.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
-$5.05M
derived: sum of 2 quarters · filed 2019-03-01
$434.00K
derived: sum of 3 quarters · filed 2019-03-01
-$2.59M
10-K · filed 2019-03-01
2016-09-30-$4.58M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$904.00K
derived: sum of 2 quarters · filed 2017-11-09
-$2.12M
10-Q · filed 2017-11-09
-$1.99M
derived: sum of 4 quarters · filed 2018-03-01
2016-06-30$5.49M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$2.46M
10-Q · filed 2017-08-09
$2.59M
derived: sum of 3 quarters · filed 2018-03-01
-$112.92M
derived: sum of 4 quarters · filed 2018-03-01
2016-03-31-$3.02M
10-Q · filed 2017-05-10
-$2.90M
derived: sum of 2 quarters · filed 2018-03-01
-$118.40M
derived: sum of 3 quarters · filed 2018-03-01
$8.30M
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31$124.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
-$115.38M
derived: sum of 2 quarters · filed 2018-03-01
$11.32M
derived: sum of 3 quarters · filed 2018-03-01
$12.14M
10-K · filed 2018-03-01
2015-09-30-$115.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$11.20M
derived: sum of 2 quarters · filed 2016-11-09
$12.01M
10-Q · filed 2016-11-09
$11.13M
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30$126.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
$127.52M
10-Q · filed 2016-08-09
$126.63M
derived: sum of 3 quarters · filed 2017-03-01
$123.17M
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31$815.00K
10-Q · filed 2016-05-10
-$74.00K
derived: sum of 2 quarters · filed 2017-03-01
-$3.54M
derived: sum of 3 quarters · filed 2017-03-01
-$3.42M
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31-$889.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
-$4.35M
derived: sum of 2 quarters · filed 2017-03-01
-$4.24M
derived: sum of 3 quarters · filed 2017-03-01
-$4.33M
10-K · filed 2017-03-01
2014-09-30-$3.46M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
-$3.35M
derived: sum of 2 quarters · filed 2015-11-09
-$3.44M
10-Q · filed 2015-11-09
-$2.85M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$110.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
$18.00K
10-Q · filed 2015-08-10
$613.00K
derived: sum of 3 quarters · filed 2016-02-29
$550.00K
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31-$92.00K
10-Q · filed 2015-05-11
$503.00K
derived: sum of 2 quarters · filed 2016-02-29
$440.00K
derived: sum of 3 quarters · filed 2016-02-29
$516.00K
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$595.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$532.00K
derived: sum of 2 quarters · filed 2016-02-29
$608.00K
derived: sum of 3 quarters · filed 2016-02-29
$644.00K
10-K · filed 2016-02-29
2013-09-30-$63.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13
$13.00K
derived: sum of 2 quarters · filed 2014-11-13
$49.00K
10-Q · filed 2014-11-13
$134.00K
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30$76.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14
$112.00K
10-Q · filed 2014-08-14
$197.00K
derived: sum of 3 quarters · filed 2015-03-02
$55.00K
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31$36.00K
10-Q · filed 2014-05-09
$121.00K
derived: sum of 2 quarters · filed 2015-03-02
-$21.00K
derived: sum of 3 quarters · filed 2015-03-02
2012-12-31$85.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
-$57.00K
derived: sum of 2 quarters · filed 2015-03-02
$121.00K
10-K · filed 2015-03-02
2012-09-30-$142.00K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-07
$36.00K
10-Q · filed 2013-11-07
2012-06-30$178.00K
10-Q/A · filed 2013-10-21
2011-12-31-$33.00K
10-K · filed 2014-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
NewAmsterdam Pharma Co N.V. (NAMS)$2.719B-15.37
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Immunome Inc. (IMNM)United States$2.538B-9.45
SUPERNUS PHARMACEUTICALS, INC. (SUPN)United States$2.517B-24.63
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
SELLAS Life Sciences Group, Inc. (SLS)United States$2.420B-91.87
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67